Keck School Faculty

David Alan Ginsberg, MD
David Alan Ginsberg, MD
Professor of Clinical Urology
Urology
NOR 7416 Health Sciences Campus Los Angeles
David Alan Ginsberg, MD is a native Southern Californian who earned his bachelor’s degree at the University of California at Berkeley. He subsequently returned to Los Angeles where he completed medical school and urology residency at the Keck School of Medicine of USC and its affiliated hospital, Los Angeles County Medical Center. Dr. Ginsberg finished his training at UCLA where he completed a fellowship focused on female urology, voiding dysfunction and urologic reconstruction.

Dr. Ginsberg is board certified in Urology and Female Pelvic Medicine & Reconstructive Urology and is also a Fellow of the American College of Surgeons. In addition to his faculty appointment at USC, Dr. Ginsberg is Chief of Urology at Rancho Los Amigo National Rehabilitation Center. Dr. Ginsberg’s clinical practice is focused on female pelvic medicine, which includes urinary incontinence and pelvic organ prolapse, neurogenic bladder and male voiding dysfunction.

Dr. Ginsberg’s present research interests focus on lower urinary tract reconstruction in spinal cord injury patients, urologic applications of botulinum toxin and long-term follow-up issues for patients with neurogenic bladder. Dr. Ginsberg is the author or co-author of over 70 peer-reviewed articles, numerous book chapters and is a regular reviewer for journals such as Journal of Urology, Urology, Neurourology & Urodynamics and Neurosurgery. He has held several visiting professorships and has been invited to lecture on multiple occasions throughout the United States and the world. He is on the urological editorial board for Medscape and was a member of the American Urological Association/American Board of Urology Exam Committee. Dr. Ginsberg is a present member of the American Urological Association Stress Incontinence Guidelines Panel.

5-cm urethral cuff at higher risk? Neurourol Urodyn. 2019 Jan; 38(1):187-192.. View in PubMed

Spinal cord stimulation ameliorates detrusor over-activity and visceromotor pain responses in rats with cystitis Neurourol Urodyn. 2019 Jan; 38(1):116-122. . View in PubMed

Spinal cord stimulation ameliorates detrusor over-activity and visceromotor pain responses in rats with cystitis Neurourol Urodyn. 2018 Nov 09. . View in PubMed

Surveillance and management of urologic complications after spinal cord injury World J Urol. 2018 Oct; 36(10):1545-1553. . View in PubMed

5-cm urethral cuff at higher risk? Neurourol Urodyn. 2018 Sep 24.. View in PubMed

Surveillance and management of urologic complications after spinal cord injury World J Urol. 2018 May 29. . View in PubMed

Surviving Fournier's gangrene: Multivariable analysis and a novel scoring system to predict length of stay J Plast Reconstr Aesthet Surg. 2018 May; 71(5):712-718. . View in PubMed

Neobladder-Vaginal fistula: The University of Southern California experience Neurourol Urodyn. 2018 Apr; 37(4):1380-1385. . View in PubMed

Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline J Urol. 2017 Oct; 198(4):875-883. . View in PubMed

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder J Urol. 2017 Oct; 198(4):897-904. . View in PubMed

Editorial Comment J Urol. 2017 Jul; 198(1):210. . View in PubMed

Urologic Management and Complications in Spinal Cord Injury Patients: A 40- to 50-year Follow-up Study Urology. 2017 Jun; 104:52-58. . View in PubMed

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis BJU Int. 2017 11; 120(5):611-622. . View in PubMed

Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications Neurourol Urodyn. 2017 04; 36(4):1155-1160. . View in PubMed

OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro J Urol. 2017 01; 197(1):11-13. . View in PubMed

OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro J Urol. 2017 Jan; 197(1):11-13. . View in PubMed

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 35-Year Study. J Urol. 2016 Sep; 196(3):791-800. . View in PubMed

Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal J Urol. 2016 Aug; 196(2):484-9. . View in PubMed

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison BMJ Open. 2016 Feb 23; 6(2):e009122. . View in PubMed

Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life Eur Urol. 2016 Feb; 69(2):247-53. . View in PubMed

Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications Urology. 2016 05; 91:46-51. . View in PubMed

Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management StrategiesArch Phys Med Rehabil. 2015 Sep; 96(9 Suppl):S341-57. e1. . View in PubMed

Editorial comment J Urol. 2015 Jun; 193(6):2094; discussion 2094. . View in PubMed

Outcomes of Male Sling Mesh Kit Placement in Patients with Neuropathic Stress Urinary Incontinence: A Single Institution Experience Urol Int. 2015; 95(4):406-10. . View in PubMed

Neurogenic bladder: from diagnosis to management Curr Urol Rep. 2014 Oct; 15(10):448. . View in PubMed

Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury Urology. 2014 Oct; 84(4):940-5. . View in PubMed

Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics? Urol Clin North Am. 2014 Aug; 41(3):445-52, ix.. View in PubMed

Robotic sacrocolpopexy Indian J Urol. 2014 Jul; 30(3):318-25. . View in PubMed

Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder BJU Int. 2014 Mar; 113(3):484-91. . View in PubMed

Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion Neurourol Urodyn. 2013 Sep; 32(7):1010-3. . View in PubMed

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology Adv Ther. 2013 Sep; 30(9):819-33. . View in PubMed

Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder BJU Int. 2013 Aug; 112(3):373-85. . View in PubMed

Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty Neurourol Urodyn. 2013 Mar; 32(3):250-3. . View in PubMed

Optimizing therapy and management of neurogenic bladder Am J Manag Care. 2013; 19(10 Suppl):s197-204. . View in PubMed

The epidemiology and pathophysiology of neurogenic bladder Am J Manag Care. 2013; 19(10 Suppl):s191-6. . View in PubMed

Editorial comment Urology. 2012 Aug; 80(2):464-5. . View in PubMed

OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial Eur Urol. 2012 Jul; 62(1):148-57. . View in PubMed

Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity J Urol. 2012 Jun; 187(6):2131-9. . View in PubMed

Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience Urology. 2012 Jun; 79(6):1397-401. . View in PubMed

Bladder acontractility: detrusor myoplasty and other options Nat Rev Urol. 2011 Apr; 8(4):185-6. . View in PubMed

Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials Neurourol Urodyn. 2011 Apr; 30(4):563-7. . View in PubMed

Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder Urology. 2011 Jan; 77(1):24-9. . View in PubMed

Augmentation enterocystoplasty in overactive bladder: is there still a role? Curr Urol Rep. 2010 Nov; 11(6):432-9.. View in PubMed

Indications and complications of cystectomy in patients with neurogenic bladder J Urol. 2010 Jul; 184(1):10-1. . View in PubMed

Editorial comment Urology. 2010 Jun; 75(6):1308-9; author reply 1309. . View in PubMed

Editorial comment Urology. 2009 Oct; 74(4):775; author reply 776-7. . View in PubMed

Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients World J Urol. 2009 Feb; 27(1):63-8. . View in PubMed

Augmentation cystoplasty: what are the indications? Curr Urol Rep. 2008 Nov; 9(6):452-8.. View in PubMed

Chinese urologists' practice patterns of diagnosing and treating chronic prostatitis: a questionnaire survey Urology. 2008 Sep; 72(3):548-51. . View in PubMed

Factors influencing the diagnosis and treatment of chronic prostatitis among urologists in China Asian J Androl. 2008 Jul; 10(4):675-81. . View in PubMed

Evaluating and managing constipation in the elderly Urol Nurs. 2007 Jun; 27(3):191-200, 212; quiz 201. . View in PubMed

Management of the neurogenic bladder in the female patient Curr Urol Rep. 2006 Sep; 7(5):423-8. . View in PubMed

Combined radical prostatectomy and bladder augmentation for concomitant prostate cancer and detrusor instability Urology. 2005 May; 65(5):964-7. . View in PubMed

Bladder neck closure with lower urinary tract reconstruction: technique and long-term followup J Urol. 2004 Dec; 172(6 Pt 1):2296-9. . View in PubMed

Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women J Urol. 2004 Jul; 172(1):219-21. . View in PubMed

Transurethral injection of bulking agents for stress urinary incontinence following orthotopic neobladder reconstruction in women J Urol. 2004 Jul; 172(1):244-6. . View in PubMed

Thrombosed urethral hemangioma J Urol. 2003 Nov; 170(5):1942. . View in PubMed

Vaginal vault prolapse: evaluation and repair Curr Urol Rep. 2003 Oct; 4(5):404-8. . View in PubMed

Urinary retention in a patient with West Nile virus Urology. 2003 Jun; 61(6):1259. . View in PubMed

Continent lower urinary tract reconstruction in the cervical spinal cord injured population J Urol. 2003 Jun; 169(6):2184-7. . View in PubMed

Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence J Urol. 2003 Jan; 169(1):199-202. . View in PubMed

Long-term urodynamics followup of bladder augmentation for neurogenic bladder J Urol. 2003 Jan; 169(1):195-8. . View in PubMed

Indications and technique of the orthotopic neobladder in women Urol Clin North Am. 2002 Aug; 29(3):725-34, xi. . View in PubMed

Permanent urinary retention after transurethral injection of collagen J Urol. 2002 Feb; 167(2 Pt 1):648. . View in PubMed

Powered by SC CTSI
Go to Top